There have been two recent trends in living kidney donation: increased acceptance of living donors and increased acceptance of laparoscopic nephrectomy (LN). We surveyed 234 UNOS-listed kidney transplant programs to determine current living donor morbidity and mortality for open nephrectomy, hand-assisted LN, and non-hand-assisted LN. Morbidity and mortality for living donor nephrectomy at transplant centers in the United States remain low. We provide current data from which comprehensive informed consent can be obtained from donors.
Introduction
Two major recent developments have led to the increased acceptance of living kidney donation. First, kidney transplant results have improved, so more patients with end-stage renal disease (ESRD) have opted for a transplant rather than dialysis. At the same time, the number of cadaver kidneys available has not increased. Thus, the waiting time for a cadaver kidney transplant has progressively increased, and, for the first time, a significant portion of patients on the waiting list are dying before receiving a cadaver kidney (1). In the last few years, as a partial solution to the cadaver kidney shortage, the number of living kidney donors has markedly increased (2).
Second, the introduction of laparoscopic nephrectomy (LN) has been associated with less pain and a quicker recovery time than conventional open nephrectomy (3, 4) . As a result, more potential living donors may volunteer (5) .
The major disadvantage of a living donor transplant is the risk to the donor, including perioperative morbidity and mortality, plus the long-term risk of living with a single kidney. Morbidity and mortality after open nephrectomy were described a decade ago (6, 7) .
Nonetheless, we were concerned that (a) the pressure to increase acceptance of living donors may have led to relaxation of acceptance criteria and a resultant change in donor outcomes and (b) the morbidity and mortality rates with LN may differ from those of open nephrectomy. Thus, to address current donor morbidity and mortality rates, we conducted a survey of transplant centers in the United States.
Methods
A survey was sent to all transplant centers listed with the United Network for Organ Sharing (UNOS).
The Human Subjects Committee at the University of Minnesota determined that the survey was exempt from review under federal guidelines [45 CFR Part 46-101 (b) Category #4]. The research project was also reviewed by the Investigational Review Board of the University of Maryland School of Medicine, which also found it exempt from formal review (exemption number STB-070201). We asked centers to provide the total number of donors they accepted between January 1, 1999, and July 1, 2001, and then the total number performed using each surgical technique: open nephrectomy, hand-assisted (HA) LN, and non-HA LN. For each of these three techniques, we asked for information on mortality, reoperation, complications, and readmissions. For donors having problems (reoperation, complications, readmissions) after either type of LN, we asked whether the problems occurred early or late in the center's experience (< 25 cases, 25-50 cases, or > 50 cases). Finally, we asked whether centers were aware of donors being denied health insurance or life insurance as a consequence of uninephrectomy.
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The incidence of reoperation, complications, and readmissions was compared among the three procedures using chi-square and/or Fisher's exact tests.
Results
Of 234 kidney transplant centers surveyed, 171 (73%) responded. Between January 1, 1999, and July 1, 2001, these centers carried out 10 828 living donor (LD) nephrectomies. This represents 85% of living donor transplants reported to the UNOS in this interval. Of these, 5660 (52.3%) were carried out by open nephrectomy, 2239 (20.7%) by HA LN, and 2929 (27%) by non-HA LN.
Of the 10 828 donors, two (0.02%) died from surgical complications (one from pulmonary embolus on postoperative day 5 after HA LN; one unspecified, also after LN). A third donor is in a persistent vegetative state after an intraoperative bleed and hypotension during non-HA LN (carried out within the first 25 cases of the center's experience). Including all three of these donors, the calculated overall mortality rate has been 0.03%. In addition, two other donors have died from nonoperative causes (one murder and one suicide, each at 6 months after donation). Table 3 ). These numbers are likely underestimated. For example, some centers may not have reported bleeding requiring transfusions unless reoperation resulted.
One unusual complication (rhabdomyolysis) (n = 6.0.1%) seemed to be related to large donors and a prolonged operative time. The occurrence of bleeding (not requiring reoperation) and of rhabdomyolysis seemed to have no relation to the center's LN experience (Table 4) .
Reasons for readmissions are shown, by donation technique, in Table 5 . Our survey separated readmissions by open nephrectomy vs. LN, but did not separate HA LN from non-HA LN. The readmission rate was significantly increased for LN donors (p < 0.001), almost entirely as a result of gastrointestinal complications (nausea and vomiting, dehydration, ileus, or constipation). It is unclear how much of this increase was the result of the intraperitoneal approach or how much was because of the goal of early hospital discharge after LN. For 45 readmissions after LN, we were able to determine the donation technique: we found no difference in reasons for readmissions for HA LN vs. non-HA LN donors (Table 6 ).
Finally, five centers reported that one or more donors have had difficulty obtaining health insurance or life insurance. For three of these centers, the issue was quickly resolved after direct communication between the center and the insurance company. One donor who was denied personal insurance was eventually covered by a spouse's policy.
Discussion
The most challenging dilemma in kidney transplantation today is an insufficient number of suitable organs for transplantation and the resultant increased waiting time for prospective cadaver donor recipients. In the last decade, the number of patients on the waiting list for a kidney in the United States has increased from 19 046 to 47 831 (2) and the median time from listing to transplant has increased from 514 to more than 1131 days. One potential solution to this problem is to increase the number of LD transplants. In 2001, the number of LD donors exceeded the number of cadaver donors.
In addition to the longer waiting times for a cadaver kidney, other possible reasons for this recent LD increase include the following: First, patient and graft survival rates after LD transplants are better than after cadaver transplants (8) . Outcome after preemptive transplants (which are much more likely with LD) is better than outcome for patients on dialysis pretransplant (9,10). Clearly, from a recipient perspective, an LD transplant is better. Second, numerous studies have shown that outcome after living unrelated donor transplants is similar to outcome after non-HLA-identical living related donor transplants (11, 12) . Acceptance of unrelated donors significantly increases the potential donor pool. Third, LN is now an attractive option, so more recipients appear to be more receptive to accepting an LD kidney (5).
The major disadvantage of LD transplants is the risk to the donor: both the operative risk and the long-term risk of living with one kidney. The operative risk has previously been described for open nephrectomy. Perioperative mortality is 0.03% (6,7); complications, mostly minor, occur in < 10% of donors (13) . To date, follow-up studies have not shown increased long-term risk after open nephrectomy (6, 14) , but it is recognized that some donors have eventually developed renal failure (15).
Our current survey also suggests that, with the introduction of LN, perioperative mortality is unchanged from a decade ago. Of 10 828 donors between January 1, 1999, and July 1, 2001, two have died and one is in a persistent vegetative state (a total of 0.03%). A concern is that all three of these donors had undergone LN. Certainly, the intraoperative bleed and the 'unspecified' case may have been related to the surgical technique. But the third problem, fatal pulmonary embolus, has been reported after open nephrectomy; in fact, it was the most common cause of death in a previous survey (6).
To date, reoperation was carried out in < 1% of all donor nephrectomy cases. Although we noted a statistically significant difference in reoperation rates between the two techniques, the difference was small. Reasons for reoperation did differ. Bleeding was a more common etiology with non-HA LN donors; bowel obstruction, with HA LN donors; and hernia, with HA LN and open nephrectomy donors. It is unknown whether additional LN experience will result in lower reoperation rates. Our data would suggest that complications occurred in centers with both a large and small experience. In addition, in centers with a large experience, complications occurred late as well as early. However, we did not differentiate between a center's experience and an individual surgeon's experience. It may be that some complications occurring late in centers with a large experience actually were early in an individual surgeon's experience. One difference that will persist is that LN is an intraperitoneal operation whereas open nephrectomy is a retroperitoneal operation (although retroperitoneal LN has been described [16] (4, 17) . It may be that a slightly increased readmission rate for a small number of donors will ultimately be an acceptable outcome in exchange for a shorter hospital stay for the majority. Future studies could resolve this question by looking at total hospitalization time.
Only five responding centers (3%) reported 1 donor having trouble obtaining health insurance or life insurance. For three centers, this problem was easily resolved. In all, only two donors were actually denied insurance: one of them was eventually covered under a spouse's policy. Spital et al. previously reported on the willingness of almost all insurance companies to provide health insurance or life insurance to donors, without increased rates (18) . Our survey supports their findings.
We recognize that our study has the inherent weakness associated with a retrospective survey. First, only 73% of centers (representing 85% of transplants) responded. It is possible that centers with more complications were less likely to respond to the survey, and thus we may have underestimated the complication rate. Second, we asked open-ended questions about reoperation, complications, and readmissions. Whereas 'reoperation' and 'readmissions' are relatively specific, 'complications' may have been interpreted differently by different centers. Third, we did not ask about laterality of the kidneys removed. We believe that a well-designed prospective study will be able to address these issues. We support the establishment of an LD registry to track both short-and long-term consequences (e.g. death, need for a transplant, renal function, readmissions, complications) of donor nephrectomy (19). In summary, morbidity and mortality after donor nephrectomy remain low. Our survey found some differences between donation techniques in the rates of reoperation, complications, and readmissions -all higher with LN. But for each technique, each of these three rates was 1.3%. Importantly, unlike other surgical patients, organ donors undergo an operation without any anticipation of physical benefit. It is essential that the risks be clearly explained to potential donors. Our survey provides current data from which comprehensive informed consent can be obtained from donors.
